Search

everythinglearnresearchcommunity

for

Search:↓

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Cosmetic treatments like bleaching and perming can greatly reduce opiate levels in hair, possibly leading to false-negative drug tests.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Certain alkaloids could help create new coronavirus drugs.

The compound 4c showed strong potential as an anticancer agent.

Analog 23 is a promising compound for prostate cancer treatment.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

TRPV channels are important in osteoarthritis and could be key to new treatments.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Hair can absorb and transfer opiates when soaked in water, with damaged hair absorbing more.

A PEG-400/oleic acid mixture best improves drug delivery monitoring through hair follicles.